The MSWA Multiple Sclerosis & Neurological Care Accelerator supports early-stage startups developing breakthrough technologies to improve the lives of people living with neurological conditions. Delivered by MSWA and Founders Factory, this 16-week hybrid programme provides capital, expert-led venture building, clinical access, and a global support ecosystem.
This accelerator fast-tracks solutions in AI-driven health, robotics, digital health, wearables, frontier science, and innovations for First Nations communities. Startups joining the programme receive hands-on support across product development, commercialisation, data science, operations, partnerships, and fundraising—helping founders validate, scale, and fund high-impact technologies.
Location: Perth (hybrid) + Virtual
Program Length: 16 weeks
Level: Early-stage startups
Applications: Open now
Focus: Multiple sclerosis, stroke, Parkinson’s, Huntington’s disease, motor neurone disease, acquired brain injury
Benefits
- Cash investment, plus opportunities for follow-on funding
- 16 weeks of expert-led venture building, covering product, commercialisation, data science, operations, partnerships, and fundraising
- Clinical access and collaboration pathways with MSWA and partner health organisations
- Global venture ecosystem of founders, operators, mentors, and investors
- Playbooks, systems, and processes to strengthen and de-risk startup growth
- AU$500,000+ in perks from top-tier software and service providers
- Exposure to a global network of clinicians, researchers, and health tech leaders
Who Should Apply
Startups developing solutions for neurological conditions, including:
- Multiple sclerosis
- Stroke
- Parkinson’s disease
- Huntington’s disease
- Motor neurone disease
- Acquired brain injury
Target Technologies:
- AI-driven healthcare
- Robotics and mobility enhancement
- Wearables and digital health
- Scientific and next-generation vaccine innovations
- Health solutions tailored for First Nations communities
- Frontier neurotech and advanced biomedical breakthroughs
Program Focus Areas
- Neurological care innovation
- Assistive robotics & mobility
- Equity-driven health solutions
- Scientific and clinical breakthroughs
- High-impact frontier health technologies
How to Apply
Applications are now open.
Apply here.
The MSWA Multiple Sclerosis & Neurological Care Accelerator is a 16-week global program designed for early-stage startups developing breakthrough technologies for neurological conditions such as multiple sclerosis, Parkinson’s, stroke, motor neurone disease, and brain injuries. Delivered by MSWA and Founders Factory, the accelerator provides cash investment, opportunities for follow-on funding, expert-led venture building, clinical access, and AU$500,000+ in perks. Startups working in AI-driven healthcare, robotics, wearables, digital health, advanced vaccines, frontier neuro innovations, or solutions for First Nations communities are encouraged to apply. The program supports founders in validating, developing, and scaling innovations that transform neurological care.
For more opportunities, click here.
